Which intervention should the nurse prioritize for a patient presenting with signs of severe dehydration?

A. They are often addictive: Non-opioid medications do not have the potential for psychological addiction because they do not activate the reward centers of the brain. They lack the mu-receptor agonism responsible for the cravings and compulsive use associated with opioids. This makes them ideal for patients with a history of substance abuse.

B. Primarily used for neuropathic pain: Neuropathic pain usually requires adjuvant medications like gabapentinoids or tricyclic antidepressants to stabilize nerve membranes. Non-opioids are most effective for inflammatory or musculoskeletal pain. While they can be part of a multimodal plan, they are not the primary treatment for nerve damage.

C. Result in respiratory depression: One of the greatest safety advantages of non-opioids is that they do not depress the respiratory center in the medulla. Even at high doses, they do not cause the life-threatening bradypnea associated with opioid toxicity. Their primary risks involve gastrointestinal, renal, or hepatic toxicity instead.

D. Useful for mild to moderate pain: Non-opioid analgesics, such as acetaminophen and NSAIDs, provide effective relief for nociceptive pain without the risk of physical dependence. Unlike opioids, they do not produce euphoria or a "high," making them safer for long-term use in non-malignant pain. They are the first step on the WHO pain ladder.

A. Conducting a new comprehensive medical history:A comprehensive history is part of the initial assessment phase of the nursing process, not the evaluation phase. While new information may emerge, the purpose of evaluation is to measure the response to specific interventions already implemented. It focuses on current outcomes rather than past medical events.

B. Reassessing patient pain level and functionality:Evaluation requires comparing the patient's current status against the established baseline and goals. The nurse must determine if the pain score has decreased and if the patient can now perform essential tasks like deep breathing. This step validates whether the chosen intervention was clinically effective.

C. Administering additional interventions from another category:Implementing new interventions is a part of the planning or implementation phases, not evaluation. Evaluation must occur first to determine if current treatments are failing before new ones are added. Prematurely changing the plan without evaluation leads to fragmented and uncoordinated patient care.

D. Assuring the patient always takes medications consistently:Monitoring medication adherence is an ongoing implementation task rather than an evaluation of the drug's efficacy. Evaluation focuses on the physiological and subjective impact of the drug on the patient's pain. Adherence does not guarantee that the prescribed dose is actually meeting the patient's needs.